Tevogen Bio Holdings, Inc. (TVGN)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$5.56-2.80%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · TVGN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name has erratic recent earnings surprises and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 117 industry peers
TVGN — private placement
Dated 2026-11-02
Entry into a Material Definitive Agreement. On October 27, 2026 (the “First Amendment Effective Date”), Tevogen Inc. (the “Company”) entered into the First Amendment to Loan Agreement (the “Amendment”) with The Patel Family, LLP (the “Lender”), amending the Loan Agreement, dated as of June 6, 2024, between the Company and the Lender (the “Original Agreement” and, as amended by the Amendment, the “Agreement”). The Original Agreement provided for an unsecured line of credit of up to $36.0 milli…
Why it matters: Nasdaq closed both compliance cases in September. Losing either listing test again could put the listing at risk.
Worry ifA new Nasdaq notice says TVGN failed the $50 million market value test or the public-share value test.
Less concerning ifNasdaq confirms TVGN still meets both market value tests, with no new compliance notice.
Why it matters: TVGN has reported losses each quarter. A smaller loss would show progress on its long-running cost goal.
Supportive ifThe November 13 earnings report shows a net loss below $5.76 million, the loss reported in 2026-Q2.
Worry ifThe November 13 report shows a net loss of $5.76 million or more.
Why it matters: Cash from operations was negative in 2026-Q1. Lower cash use would support the stated goal of managing cash flow.
Supportive ifThe next report shows cash from operations used less than $2.73 million in the quarter.
Worry ifThe next report shows cash from operations used $2.73 million or more in the quarter.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$274 on $10,000 · ±2.7% | How much price usually moves either way. |
| Bad day | $1,085 loss on $10,000 · 10.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,518 loss on $10,000 · 85.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.